UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prenatal Protease Inhibitor Use and Risk of Preterm Birth among HIV-Infected Women Initiating Antiretroviral Drugs during Pregnancy

The Journal of infectious diseases, 2010-04, Vol.201 (7), p.1035-1044

2010

Volltextzugriff (PDF)

Antiretroviral Therapy during Pregnancy and the Risk of an Adverse Outcome

The New England journal of medicine, 2002-06, Vol.346 (24), p.1863-1870

2002

Volltextzugriff (PDF)

Etravirine Pharmacokinetics in HIV-Infected Pregnant Women

Frontiers in pharmacology, 2016-08, Vol.7, p.239-239

2016

Volltextzugriff (PDF)

Darunavir Pharmacokinetics With an Increased Dose During Pregnancy

Journal of acquired immune deficiency syndromes (1999), 2020-04, Vol.83 (4), p.373-380

2020

Volltextzugriff (PDF)

Population Pharmacokinetics of Tenofovir in Pregnant and Postpartum Women Using Tenofovir Disoproxil Fumarate

Antimicrobial agents and chemotherapy, 2021-02, Vol.65 (3)

2021

Volltextzugriff (PDF)

Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s

Antimicrobial agents and chemotherapy, 2023-11, Vol.67 (11), p.e0073723

2023

Volltextzugriff (PDF)

Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV

AIDS (London), 2021-03, Vol.35 (3), p.407-417

2021

Volltextzugriff (PDF)

Missed Opportunities for Prevention of Mother-to-Child Transmission of Human Immunodeficiency Virus

Obstetrics and gynecology (New York. 1953), 2017-04, Vol.129 (4), p.621-628

2017

Volltextzugriff (PDF)

Assessing the efficacy of magnesium oxide and riboflavin as preventative treatment of migraines in pregnancy

Archives of gynecology and obstetrics, 2023-12, Vol.308 (6), p.1749-1754

2023

Volltextzugriff (PDF)

Pharmacokinetics of Saquinavir plus Low-Dose Ritonavir in Human Immunodeficiency Virus-Infected Pregnant Women

Antimicrobial Agents and Chemotherapy, 2004-02, Vol.48 (2), p.430-436

2004

Volltextzugriff (PDF)

Pharmacokinetics and Safety of Remdesivir in Pregnant and Nonpregnant Women With COVID-19: Results From IMPAACT 2032

The Journal of infectious diseases, 2024-06

2024

Volltextzugriff (PDF)

Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s

Journal of acquired immune deficiency syndromes (1999), 2022-07, Vol.90 (3), p.343-350

2022

Volltextzugriff (PDF)

Rilpivirine Plasma and Cervicovaginal Concentrations in Women During Pregnancy and Postpartum

Journal of acquired immune deficiency syndromes (1999), 2018-07, Vol.78 (3), p.308-313

2018

Volltextzugriff (PDF)

Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV: Results from IMPAACT P1026s

AIDS (London), 2021-03, Vol.35 (3), p.407-417

2021

Volltextzugriff (PDF)

Predictors of Viremia in Postpartum Women on Antiretroviral Therapy

Journal of acquired immune deficiency syndromes (1999), 2020-01, Vol.83 (1), p.72-80

2020

Volltextzugriff (PDF)

Pharmacokinetics of Increased Nelfinavir Plasma Concentrations in Women During Pregnancy and Postpartum

Journal of clinical pharmacology, 2019-03, Vol.59 (3), p.386-393

2019

Volltextzugriff (PDF)

Atazanavir pharmacokinetics with and without tenofovir during pregnancy

Journal of acquired immune deficiency syndromes (1999), 2011-04, Vol.56 (5), p.412-419

2011

Volltextzugriff (PDF)

Lopinavir tablet pharmacokinetics with an increased dose during pregnancy

Journal of acquired immune deficiency syndromes (1999), 2010-08, Vol.54 (4), p.381-388

2010

Volltextzugriff (PDF)

Reduced lopinavir exposure during pregnancy

AIDS (London), 2006-10, Vol.20 (15), p.1931-1939

2006

Volltextzugriff (PDF)

Lopinavir exposure with an increased dose during pregnancy

Journal of acquired immune deficiency syndromes (1999), 2008-12, Vol.49 (5), p.485-491

2008

Volltextzugriff (PDF)

Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022

Journal of acquired immune deficiency syndromes (1999), 2004-07, Vol.36 (3), p.772-776

2004

Volltextzugriff (PDF)

Birth Weight and Preterm Delivery Outcomes of Perinatally vs Nonperinatally Human Immunodeficiency Virus-Infected Pregnant Women in the United States: Results From the PHACS SMARTT Study and IMPAACT P1025 Protocol

Clinical infectious diseases, 2017-09, Vol.65 (6), p.982-989

2017

Volltextzugriff (PDF)

Fetal responses to maternal and fetal methamphetamine administration in sheep

American journal of obstetrics and gynecology, 1995-11, Vol.173 (5), p.1592-1598

1995

Volltextzugriff (PDF)

Lopinavir protein binding in HIV‐1‐infected pregnant women

HIV medicine, 2010-04, Vol.11 (4), p.232-238

2010

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(70)
Buchkapitel
(2)

Sprache

Englisch
(72)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(59)
Science & Technology
(59)
Female
(55)
Pregnancy
(55)
Humans
(53)
Adult
(43)
Infectious Diseases
(42)
Hiv Infections - Drug Therapy
(38)
Hiv
(36)
Immunology
(32)
Pharmacokinetics
(31)
Pregnancy Complications, Infectious - Drug Therapy
(30)
Prospective Studies
(28)
Human Immunodeficiency Virus
(26)
Biological And Medical Sciences
(23)
Medical Sciences
(23)
Postpartum Period
(22)
Antiretroviral Drugs
(21)
Microbiology
(19)
Adolescent
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prenatal Protease Inhibitor Use and Risk of Preterm Birth among HIV-Infected Women Initiating Antiretroviral Drugs during Pregnancy

Antiretroviral Therapy during Pregnancy and the Risk of an Adverse Outcome

Etravirine Pharmacokinetics in HIV-Infected Pregnant Women

Darunavir Pharmacokinetics With an Increased Dose During Pregnancy

Population Pharmacokinetics of Tenofovir in Pregnant and Postpartum Women Using Tenofovir Disoproxil Fumarate

Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s

Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV

Missed Opportunities for Prevention of Mother-to-Child Transmission of Human Immunodeficiency Virus

Assessing the efficacy of magnesium oxide and riboflavin as preventative treatment of migraines in pregnancy

Pharmacokinetics of Saquinavir plus Low-Dose Ritonavir in Human Immunodeficiency Virus-Infected Pregnant Women

Pharmacokinetics and Safety of Remdesivir in Pregnant and Nonpregnant Women With COVID-19: Results From IMPAACT 2032

Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s

Rilpivirine Plasma and Cervicovaginal Concentrations in Women During Pregnancy and Postpartum

Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV: Results from IMPAACT P1026s

Predictors of Viremia in Postpartum Women on Antiretroviral Therapy

Pharmacokinetics of Increased Nelfinavir Plasma Concentrations in Women During Pregnancy and Postpartum

Atazanavir pharmacokinetics with and without tenofovir during pregnancy

Lopinavir tablet pharmacokinetics with an increased dose during pregnancy

Reduced lopinavir exposure during pregnancy

Lopinavir exposure with an increased dose during pregnancy

Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022

Pharmacokinetics and Safety of Remdesivir in Pregnant and Non-Pregnant Women with COVID-19: Results from IMPAACT 2032

Birth Weight and Preterm Delivery Outcomes of Perinatally vs Nonperinatally Human Immunodeficiency Virus-Infected Pregnant Women in the United States: Results From the PHACS SMARTT Study and IMPAACT P1025 Protocol

Fetal responses to maternal and fetal methamphetamine administration in sheep

Lopinavir protein binding in HIV‐1‐infected pregnant women

Suchergebnisse filtern